CAMP HILL, Pa. Rite Aid Corporation Thursday morning announced a same-store sales increased of 0.7 (which does not include the Brooks and Eckerd operations) for the four weeks ended Sept. 29.
Pharmacy same-store sales increased 1.3 percent, which included an approximate 395 basis points negative impact from new generic introductions, while front-end same-store sales decreased 0.5 percent.
Total drugstore sales for the four-week period, which does include results from Brooks/Eckerd, increased 52 percent to $2 billion compared to $1.3 billion for the same period last year. Prescription revenue accounted for 68.6 percent of drugstore sales, and third party prescription revenue represented approximately 95.9 percent of pharmacy sales.
Same-store sales for the 30-week period ended Sept. 29 increased 1.6 percent (again, without Brooks/Eckerd results), consisting of a 2 percent lift in pharmacy same store sales increase and a 0.9 percent increase in front-end same store sales. Year-to-date sales totaled $13 billion, representing a 31.4 percent increase.